featured
Cabozantinib in Patients With Platinum-Refractory Metastatic Urothelial Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cabozantinib in Patients With Platinum-Refractory Metastatic Urothelial Carcinoma: An Open-Label, Single-Centre, Phase 2 Trial
Lancet Oncol 2020 Jul 06;[EPub Ahead of Print], AB Apolo, R Nadal, Y Tomita, NN Davarpanah, LM Cordes, SM Steinberg, L Cao, HL Parnes, R Costello, MJ Merino, LR Folio, L Lindenberg, M Raffeld, J Lin, MJ Lee, S Lee, SV Alarcon, A Yuno, NA Dawson, K Allette, A Roy, D De Silva, MM Lee, TM Sissung, WD Figg, PK Agarwal, JJ Wright, YM Ning, JL Gulley, WL Dahut, DP Bottaro, JB TrepelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.